Literature DB >> 25577829

[Long noncoding RNAs in prostate cancer].

Zhang-qun Ye1, Tao Wang, Wen Song.   

Abstract

Long non-coding RNAs (lncRNAs) are a group of RNA molecules which are longer than 200 nucleotides. They do not have functional open reading frames and cannot encode proteins. Recent studies have demonstrated that lncRNAs are widely involved in the regulation of gene expression network at epigenetic, transcriptional and post-transcriptional levels, which may affect the growth, proliferation, differentiation, metabolism, apoptosis and other important physiological processes of cells. The abnormal expression of lncRNAs is closely associated with the development, invasion, metastasis and prognosis of tumors. The development of prostate cancer is a multi-factor and multi-step process, in which abnormal gene expression may play an important role. This review focuses on the recent progress in the studies on the role of lncRNAs in prostate cancer, aiming for some new clues to the clinical prevention, diagnosis and treatment of this malignancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25577829

Source DB:  PubMed          Journal:  Zhonghua Nan Ke Xue        ISSN: 1009-3591


  3 in total

1.  Unregulated long non-coding RNA-AK058003 promotes the proliferation, invasion and metastasis of breast cancer by regulating the expression levels of the γ-synuclein gene.

Authors:  Kai He; Peilin Wang
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

2.  lncRNA XIST promotes glioma proliferation and metastasis through miR-133a/SOX4.

Authors:  Chixing Luo; Zhongping Quan; Bao Zhong; Ming Zhang; Bo Zhou; Shaobo Wang; Xinkai Luo; Changjiu Tang
Journal:  Exp Ther Med       Date:  2020-01-07       Impact factor: 2.447

3.  Long Non-Coding RNA SNHG1 Regulates the Wnt/β-Catenin and PI3K/AKT/mTOR Signaling Pathways via EZH2 to Affect the Proliferation, Apoptosis, and Autophagy of Prostate Cancer Cell.

Authors:  Junyi Chen; Fubo Wang; Huan Xu; Lingfan Xu; Dong Chen; Jialiang Wang; Sihuai Huang; Yiqun Wen; Longmin Fang
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.